LifeMD Inc. (LFMD)
4.72
0.00 (0.00%)
At close: Jan 14, 2025, 3:59 PM
4.73
0.11%
After-hours Jan 14, 2025, 05:23 PM EST
undefined% (undefined)
| Bid | 4.05 |
| Market Cap | 204.65M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -7.38 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 5.2 |
| Volume | 358,410 |
| Avg. Volume (20D) | 658,131 |
| Open | 4.82 |
| Previous Close | 4.72 |
| Day's Range | 4.61 - 4.85 |
| 52-Week Range | 3.99 - 12.88 |
| Beta | undefined |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical ...
Industry Medical - Pharmaceuticals
Sector Healthcare
IPO Date Jan 29, 2008
Employees 207
Stock Exchange NASDAQ
Ticker Symbol LFMD
Website https://www.lifemd.com
Analyst Forecast
According to 8 analyst ratings, the average rating for LFMD stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 153.97% from the latest price.
Buy 87.50%
Hold 12.50%
Sell 0.00%
Next Earnings Release
LifeMD Inc. is scheduled to release its earnings on Mar 10, 2025,
during market hours.
Analysts project revenue of $57.34M, reflecting a 27.82% YoY growth and earnings per share of -0.06, making a -140.00% decrease YoY.
Analysts project revenue of $57.34M, reflecting a 27.82% YoY growth and earnings per share of -0.06, making a -140.00% decrease YoY.
2 months ago ·
Source
+14.04%
LifeMD shares are trading higher after the company...
Unlock content with
Pro Subscription
7 months ago ·
Source
+7.46%
LifeMD shares are trading higher after it was announced the stock will be added to the Russell 3000 index.
